source
- Boehringer's obesity drug shows up to 9.8% weight loss in diabetes patients but lags behind competitorsBoehringer Ingelheim presented data at the European Association for the Study of Diabetes (EASD) meeting in Milan, showing its lead obesity candidate achieved up to 9.8% weight reduction in a late-…
- ICMRA urges cut to animal testing while HHS launches ARPA-H SURPASS program to accelerate clinical trialsInternational Coalition of Medicines Regulatory Authorities released a joint statement urging drug makers and national control labs to cut back on animal testing throughout a medicine’s development…